Explore the latest in acute coronary syndromes, including recent guidelines and advances in management of STEMI, NSTEMI, and unstable angina.
This cohort study assesses associations of carotid artery magnetic resonance imaging plaque characteristics with incident cardiovascular disease events.
This cohort study examines the extent to which disparities in access, treatment, and outcomes have changed for patients with ST-segment elevation myocardial infarction (STEMI) who are living in zip codes that are largely composed of Black or Hispanic individuals compared with patients in nonminority communities in regionalized vs nonregionalized counties.
This cohort study investigates the association of early-life trauma with adverse events and examines whether inflammation plays a role.
This cohort study assesses adherence to evidence-based fractional flow reserve (FFR) thresholds for percutaneous coronary intervention in Canada between 2013 and 2018, and associations of percutaneous coronary intervention with major adverse clinical outcomes for patients with FFR measures above and beneath ischemic thresholds.
This cohort study describes temporal trends and institutional variations of multivessel percutaneous coronary intervention use for ST-elevation myocardial infarction in the United States between 2009 and 2018.
This case-time-control analysis uses data from the French national health insurance database to assess whether the initiation of ustekinumab treatment is associated with triggering severe cardiovascular events.
This cohort study of patients with coronavirus disease 2019 who were hospitalized in cardiology units in Italy assesses the association of troponin levels at admission with patient outcomes.
This secondary analysis of a randomized clinical trial evaluates the testing of high-sensitivity cardiac troponin in clinical practice.
This systematic review summarizes the long-term effects of randomized clinical trials about acute coronary syndromes after the primary hypothesis was addressed or if the clinical trial did not achieve its primary objective.
This difference-in-differences analysis assesses whether an association exists between hospitals being acquired by private equity firms and hospital income, use, and quality in the United States.
This cohort study compares net risk for ischemic vs hemorrhagic events at 12 months among patients treated with ticagrelor vs clopidogrel during and after percutaneous coronary intervention (PCI) management of acute coronary syndrome (ACS).
This cohort study assesses the association of the COVID-19 pandemic with the incidence of 5 medical emergencies (acute myocardial infarction, ischemic stroke, nontraumatic subarachnoid hemorrhage, ectopic pregnancy, and appendicitis) in 2 US academic medical centers.
This cross-sectional study evaluates geographic variation and its change with time in treatment process and outcomes for patients with acute myocardial infarction in China.
This cross-sectional study examines the variations in care and outcomes of patients with acute ST-segment elevation myocardial infarction (STEMI) at 3 different levels of hospitals—province, prefecture, and county—in China.
This national cohort study evaluates trends in heart failure incidence across risk factor strata, including hypertension, diabetes, obesity, acute myocardial infarction, and atrial fibrillation among Medicare beneficiaries.
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: